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Abstract
Background
This study examined knowledge, attitudes and opinions regarding alcohol, tobacco, and other drug
(ATOD) use during pregnancy among women enrolled in drug treatment centers. It also assessed
the educational and screening practices of health care professionals who care for women of childbearing age in Utah.
Methods
The assessment of ATOD use was based on a convenience sample of women who were enrolled in
drug treatment centers in Utah. The sample (n = 60) was surveyed by trained research team
members. The assessment of screening practices of physicians and other medical professionals (n =
350) who deal with women’s obstetric and gynecological conditions was conducted via an online
survey. An in-depth interview with seven of the professionals was also conducted.
Results
Most women surveyed (72%) reported that they would follow the advice of their health care
provider regarding the use of alcohol, tobacco and other drugs (ATOD). Other sources of
information (e.g. TV, Internet and radio) were less trusted. The women also indicated that a major
barrier to disclosing an ATOD use was fear of negative consequences, both legal and social.
Analysis of data from the professionals surveyed indicated that while most do some screening, there
is a significant difference in ATOD screening practices for pregnant women and for women who are
of childbearing age but not pregnant. Further, while nearly all professionals reported educating
women who came to their clinic, fewer than 35% indicated using written educational materials.
Lack of time was indicated as the primary barrier to proper screening and education of women in
health care clinics.
Conclusion
Women who have been enrolled in treatment centers for ATOD addictions are fearful of the
negative legal and social repercussions as a result of their ATOD use and hence do not consistently
seek prenatal care. However, when information is given, most women are willing to comply with
the recommendations of their health care providers. Providers are also very interested in quality
patient care, but indicate that lack of time does not allow adequate one-on-one time with each
patient. Screening and educational practices are performed in most offices, but both the timing of
the screening and approach to patient education may not be sufficient to ensure optimal outcomes.
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Background

Health care professionals have known for decades the importance of proper health practices for
pregnant women (Phelan, 2008). Care should be taken to ensure that proper education and
consultation are given to women who are pregnant. Educational topics include proper diet,
necessary vitamin supplements and proper exercise and activity levels. Women are also advised
regarding activities or substances that can be harmful to them and the unborn child. Dew, Guillory,
Okah, Cai and Hoff (2007) indicate common substances identified as potentially harmful to unborn
children are alcohol, tobacco and other drugs (ATOD). These findings are supported by numerous
other studies. Additionally, the use of these substances significantly increases the probability of
medical complications for both mother and child during and after pregnancy.
Best practices in health care include the education of pregnant women in caring for their unborn
children. Despite these efforts, the attitudes and actions of mothers who use ATODs during
pregnancy have not changed significantly. In a study conducted from 1991-2005, Denny, Tsai,
Floyd, and Green (2009) gathered data on the incidence of alcohol use among pregnant and nonpregnant women of childbearing age. The incidence of alcohol use among pregnant women was
much lower than that of non-pregnant women (11% vs. 55% respectively in 2005). However, there
was little change in the percentage of women in 2005 who consumed alcohol during pregnancy
when compared to the group studied in 1991. Despite the emphasis on education of pregnant
mothers, the incidence of mothers using alcohol has generally remained in the 10-12% range.
Martin, et al. (2006) reported that the incidence of tobacco use among women who were pregnant
was one in 10. Further, a study by the Substance Abuse and Mental Health Services Administration
(SAMHSA) (2005) indicated that nearly 4% of pregnant women used illicit drugs during the term of
their pregnancy. These statistics are startling, especially considering most health care professionals
report educating their patients who are pregnant or planning on becoming pregnant about the
dangers of alcohol, tobacco and other drugs.
Suarez et al. (2008) indicated that while not all children born to women who use alcohol, tobacco or
other drugs during pregnancy will have disabilities and/or birth defects, researchers have discovered
that the likelihood is much higher. Statistics from the Centers for Disease Control and Prevention
(CDC) in 2006 show that about 120,000 babies (1 in 33) in the United States are born with birth
defects each year. Martin et al. (2006) noted that birth defects are the number one cause of death in
children during the first year of life. These children are therefore more likely to encounter early
mortality or disabling conditions later in life. Because many factors contribute to birth defects in
children, it is difficult to identify an exact cause, but it has been established that rates of birth
defects are higher for children born to women who use alcohol, tobacco or other drugs. Nelson and
Holmes (1989) indicate that 2-3% of all birth defects can be traced to drug use during pregnancy.
Stratton, Howe, and Battaglia (1996) identified alcohol abuse during pregnancy as the leading
preventable cause of mental retardation in offspring in the United States. Further, the most severe
consequences of maternal alcohol abuse are fetal alcohol syndrome (FAS) and alcohol-related
neurodevelopmental disorders (ARND).
This research project aimed to accomplish two primary purposes. The first was to obtain
information regarding knowledge, attitudes and opinions about the use of ATODs during pregnancy
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from mothers who were enrolled in drug or alcohol treatment centers. The second was to identify
current patient ATOD screening and educational practices of physicians and other professionals
who specialize in caring for women of childbearing age in the state of Utah.
Methods
Study Sample
Two separate samples were used for this research study. The first sample was comprised of women
of childbearing age (with or without children) enrolled in one of three urban drug treatment centers
in Utah. Two of the centers were located in Salt Lake County and the third was in Davis County.
All three centers are located in urban areas. These centers were selected as they have consistently
had a higher number of pregnant women enrolled in treatment programs (Utah Department of
Human Services, Division of Substance Abuse and Mental Health (DSAMH) Annual Report, 2008).
The second sample consisted of physicians and other health care professionals who regularly treat
pregnant women and women of childbearing age for obstetric and gynecological conditions. This
sample was gathered utilizing the database of the Utah Division of Occupational and Professional
Licensing (DOPL), which regulates licenses for medical and other professions in the state of Utah.
Provider titles were identified and included: nurse, osteopathic physician (surgeon/controlled
substance), certified nurse midwife, naturopath, physician assistant and others.
Data Collection
Survey of Women in Drug Treatment Centers
Data were collected from the women in the three treatment centers via a structured survey. This
survey instrument was developed collaboratively by the Utah Department of Health and the Davis
County treatment facility staff. Anonymity was ensured by excluding all personal identifiers from
the responses. It was determined by the Utah Department of Health’s IRB that approval was not
needed when implementing a survey with no personal identifiers. The survey consisted of four
open-ended questions, six questions with multiple choice answers and 10 questions based on a
three-point Likert scale (Appendix 1). Basic demographic information was collected via two
multiple choice questions on age and race/ethnicity. To ensure consistency in conducting the
survey, training was done for the two people who conducted the survey in the treatment centers. A
total of 60 surveys were completed.
Survey and Interview of Health Care Professionals
Two levels of information were gathered from the professionals. First was an online survey
regarding their practice of educating women who seek their health care. The survey was developed
by the Utah Department of Health with review/edits by a neonatologist and an obstetrician. A
popular web-based survey tool (Zoomerang™) was used to administer the survey online. The
survey URL was sent to 2,045 professionals who were listed in the DOPL database via email. In
order to improve the response rate, several reminder notices were sent and the time to complete the
survey was extended. A total of 350 professionals completed the online survey with a response rate
of 17%. This survey consisted of 22 questions including Likert scale, multiple choice and yes/no
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questions, as well as open-ended questions (see Appendix 2). There were also two questions
inquiring about the participant’s interest in receiving further information on educational materials.
Telephone interviews of selected professionals were a second level of information gathering. These
seven professionals had indicated a willingness to participate in the telephone survey as a part of the
online survey. The purpose of the interview was to gather additional information on the methods
used to educate the client. The interview included both yes/no questions as well as open-ended
questions, allowing the professionals to elaborate on responses regarding their current practices
(Appendix 3).
Results
Participant characteristics
Women in the study who were pregnant or of childbearing age were residents of one of three drug
rehabilitation centers in Salt Lake and Davis counties. Age and race/ethnicity information was
reported by 43 of 60 respondents (71.7%). Of these, 96% were over 20 years old with 49% being
between ages 20-29. The majority identified themselves as White 74% (n=32) and 5% (n=2)
identified themselves as Hispanic. All 60 respondents disclosed the source of their referral to the
treatment center. Referral source was most often from law enforcement or courts (48.3%) or
counseling/self-search (40.0%). Only 11.7% were referred by health care workers, family or friends.
Participant knowledge, attitudes and opinions related to ATOD and pregnancy
Participants’ responses revealed various attitudes, knowledge and opinions regarding the use of
ATOD during pregnancy. Several questions were designed to identify the participant’s willingness
to follow instructions and warnings given by common sources. The question was, “If a doctor talks
to you about health information, would you follow the advice?” Similar questions were asked
regarding radio, TV and online sources of information. The participant responses are shown in
Table 1.
Table 1. Source of Information
Source of Information
Health Care Provider

“I would follow”
% (n)

“I might follow”
% (n)

“I would not follow”
% (n)

72.2% (39)

27.8% (15)

0.0% (0)

Radio

9.2% (5)

77.8% (42)

13.0% (7)

TV

5.5% (3)

75.9% (41)

16.6% (9)

Online (Internet)

14.8% (8)

77.7% (42)

5.5% (3)

When researchers probed participants’ opinions regarding effective slogans and messages designed
to promote awareness and prevent ATOD use during pregnancy, the respondents selected the
following top three slogans and messages. More than one response was allowed.

5

The top three slogans were:
1. “Drugs can harm a baby before and after it is born.” (48 responses)
2. “Drinking any kind of alcohol when you are pregnant can hurt your baby.” (44
responses)
3. “Smoking can harm an unborn baby.” (42 responses)
The top three positive messages of encouragement identified were:
1. “It is never too late to stop using a drug. A mother who stops using drugs at any time
during pregnancy increases the chance that her baby will be born healthy.” (46
responses)
2. “Drugs and alcohol don’t have to be part of your or your baby’s life.” (45 responses)
3. “Stopping drinking can be very hard. But there are many people who will help you.” and
“Even if you have tried to stop drinking before, try again. Don’t give up.” (40 responses
each)
Participant barriers to obtaining appropriate treatment for ATOD problems
Participants were asked to provide the reasons for not seeking treatment for ATOD. The main
reasons for not seeking treatment are displayed in Figure 1. Respondents were allowed to include
more than one reason for not seeking treatment.
Figure 1. Reasons for Not Seeking Treatment
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The most commonly stated reason for not seeking treatment was the inability to pay for a substance
abuse program, followed closely by the belief that the treatment wouldn’t work. Responders stated
that the concern that they would have to wait for treatment and the fear of losing their children tied
as the third most common reason for not seeking treatment.
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In response to the question regarding sources of health information, 43.3% indicated that they
obtained their health information from their health care provider and 20.0% from the treatment
centers. The remaining 36.7% of respondents indicated that they obtained health information from
either friends, family, media or other sources.
Participants were also asked the question, “If you wanted help to quit drinking or using substances,
where would you go for information about treatment services?” More than half (53.3%) responded
that they would seek information from the treatment centers, 18.3% from the courts, probation
officer or DCFS and 28.3% from either friends, family, health care provider or other sources.
Physician and health care professional participant characteristics
Physicians and other health care professionals in Utah were surveyed online regarding current
educational practices in dealing with ATOD use for women during their childbearing years. These
professionals were primarily physicians, with a relatively large number of licensed nurse
practitioners and certified nurse-midwives. The breakdown of type of primary professions is shown
in Figure 2. The majority (79.1%) of professionals reported practicing in urban locations.
Figure 2. Type of Primary Profession
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Physician and health care professional screening and educational practices
Professionals were asked to respond to several questions, including how often they screened women
of childbearing age and pregnant women for ATOD use and who, if anyone, performed the
screening. Table 2 shows when the woman was screened and whether the patient was pregnant or of
childbearing age. Data show that professionals were more likely to screen for any type of drug use
in pregnant women compared to non-pregnant women of childbearing age.
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Table 2. Screening Practices of Health Care Professionals
Type of
patient*

Substance
type

Initial
visit
% (n)

Every
visit
% (n)

Annually
% (n)

When
problems are
suspected
% (n)

Never
% (n)

Pregnant

Alcohol

48.2%

23.1%

1.2%

17.9%

9.6%

(121)

(58)

(3)

(45)

(24)

47.0%

27.1%

1.2%

13.9%

10.8%

(118)

(68)

(3)

(35)

(27)

47.4%

16.7%

1.2%

23.9%

10.8%

(119)

(42)

(3)

(60)

(27)

Prescription
Drugs

40.6%

16.7%

1.2%

28.3%

13.1%

(102)

(42)

(3)

(71)

(33)

Childbearing age

Alcohol

34.4%

24.5%

11.7%

23.1%

6.2%

(94)

(67)

(32)

(63)

(17)

Childbearing age

Tobacco

34.8%

34.1%

13.9%

11.7%

5.5%

(95)

(93)

(38)

(32)

(15)

Childbearing age

Illicit Drugs

30.4%

18.0%

11.4%

33.7%

6.6%

(83)

(49)

(31)

(92)

(18)

Childbearing age

Prescription
Drugs

23.4%

20.1%

8.1%

39.2%

9.2%

(64)

(55)

(22)

(107)

(25)

Pregnant
Pregnant
Pregnant

Tobacco
Illicit Drugs

*Pregnant Women N=251; Women of Childbearing age N=273

Further, 74% of professionals reported that in their medical practices, either a medical doctor (M.D.
or D.O.) or medically trained staff (RN, PA, NP, CNM or APRN) performed the screening. The
remaining 26% responded that non-medically trained staff (e.g. hospital staff, receptionist, etc.)
performed the screening.
When asked how much time was spent on the screening, the most common response was “less than
five minutes” (46.3%). Nearly twenty-eight percent (27.8%) indicated they spent more than five
minutes. Nearly to four percent (3.7%) reported not spending any time on ATOD education with
their patients (see Table 3).
Table 3. Time Spent with Patient
Time
None
Less than 5 minutes
Less than 10 minutes
10 to 15 minutes
More than 15 minutes
Other
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Percent

Number

3.7
46.3
13.5
9.0
5.3
22.1

9
113
33
22
13
54

Of the professionals who responded to questions regarding educational practices with women of
childbearing age, only 34.7% indicated that they have used written ATOD educational material. The
type of educational material used by professionals varied and some practices used more than one
type. Providers were encouraged to indicate all types of educational formats used with patients. This
allowed them to choose more than one format listed on the survey. The results indicated that 55
used a brochure, 37 used a fact sheet, 21 used a website and 13 used another format, including
books, newsletters, posters or other appropriate media (see Table 4). Very few professionals
indicated the origin of their media, but it was apparent that there were diverse resources, including
professional associations (e.g. American Medical Association), private entities, government
agencies, self-production of educational materials and various other sources.
Table 4. Education Tools Used in Health Care Provider Office
Do you use any ATOD education
materials when talking to patients?

Percent

Yes

34.7
64.7
43.5
24.7
15.3
65.3

Brochure
Fact sheet
Website
Other
No

Number
85
55
37
21
13
160

When asked if they would be interested in receiving additional ATOD educational information to
use with their patients, more than half (59.7%) responded affirmatively. Practitioners were
encouraged to choose more than one format for information to be disseminated if desired. Of these,
the preferred format was a fact sheet (114) followed by brochure (106), websites (71) and CD/DVD
(24). Spanish translation of information was also requested.
Table 5. Request for Educational Tools
Would you be interested in
receiving substance abuse
educational material/tools?
Yes

Percent

Number

59.7
Brochure
Fact sheet
Website
CD / DVD
Other

No

142
74.6
80.3
50.0
16.9
7.0

40.3

106
114
71
24
10
96

Barriers to appropriate screening and education of patients
More than half of the health care professionals responded that they felt there were no barriers to
screening or education with either group of women. While most indicated that there were sufficient
resources, time was identified as the main obstacle (see Table 6).
Table 6. Barriers to Screening
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Type of
patient*

Substance
type

Not
enough
time
% (n)

Not enough
information
on effects
% (n)

Not enough
information
on treatment
% (n)

No
contacts to
refer
patient to
% (n)

Pregnant

Alcohol

Pregnant

Tobacco

Pregnant

Illicit Drugs

Pregnant

Prescription
Drugs
Alcohol

13.9%
(35)
13.9%
(35)
14.7%
(37)
15.1%
(38)
22.3%
(61)
20.9%
(57)
21.6%
(59)
21.6%
(59)

0.8%
(2)
0.8%
(2)
2.0%
(5)
2.0%
(5)
0.4%
(1)
0.7%
(2)
1.1%
(3)
1.8%
(5)

3.6%
(9)
3.2%
(8)
4.8%
(12)
5.2%
(13)
4.8%
(13)
4.0%
(11)
6.6%
(18)
5.5%
(15)

10.8%
(27)
7.6%
(19)
14.7%
(37)
12.7%
(32)
15.8%
(43)
11.0%
(30)
18.7%
(51)
17.2%
(47)

Childbearing age
Childbearing age
Childbearing age
Childbearing age

Tobacco
Illicit Drugs
Prescription
Drugs

No
barriers
% (n)

60.2%
(151)
63.8%
(160)
51.8%
(130)
53.8%
(135)
50.5%
(138)
56.0%
(153)
44.7%
(122)
46.9
(128)

Not
applicable
% (n)

10.8%
(27)
10.8%
(27)
12.0%
(30)
11.2%
(28)
6.2%
(17)
7.3%
(20)
7.6%
(20)
7.0%
(19)

*Pregnant Women N=251; Women of Childbearing age N=273

Physician Interviews
Screening practices of professionals
Following the online survey, eight medical practices were chosen to complete a brief telephone
interview. Seven agreed to participate. All participating professionals stated that all women who
came to their practice were screened. Four of seven indicated that they screened pregnant women
more often than non-pregnant women and the remaining three noted no difference. The primary
reason for the difference was the increased emphasis on the harm that ATOD has on the baby for
pregnant women. Additionally, six of the seven professionals reported they did not use the
screening sample tools Pregnancy Risk Line (PRL) had sent to their offices (Standard Drink Card;
Assess Readiness; Additional Screening and Intervention Tools and Strategies for Change created
by the American College of Obstetricians and Gynecologists with support by the U.S. Department
of Health and Human Services, Centers for Disease Control and Prevention). They reported that
their tools were shorter and developed in their office. They noted that the information gathered by
their screening tool was similar to the information on the samples that were sent.
Educational practices of professionals
Five of seven professionals mentioned that they provide ATOD education for all women of
childbearing age while two responded that they provide education only for those who are pregnant.
Most commented that they do emphasize the effects of ATOD more often to women who are
pregnant. All seven health care provider offices responded that they used verbal communication to
convey important information. Additionally, five used print media (e.g. brochures, fact sheets, etc.).
One included a sheet with pertinent websites in a “pregnancy” packet given to pregnant women on
their first visit. Four of the seven responded that they thought their method of sharing information

10

was effective while two thought it depended on the individual and one thought that it was
ineffective.
The professionals were also asked several open-ended questions. They were asked why they felt
that fewer than 60% of offices were interested in receiving more information regarding ATOD
screening and education for patients. Responses included:
“Doctors in Utah County don’t think it is really an issue in the area. There is an overload of
information coming into the clinic.”
“Doctors have a lack of knowledge about how prevalent these issues really are. There is
ignorance about the scope of the problem.”
Interviewees were then asked what might help emphasize the need to screen all women for ATOD.
Responses were as follows:
“Doctors need to be more aware of the prevalence of the problem and they need more
statistics to educate doctors about the scope of the problem.”
“Information needs to really stand out and not just be more of the same—it’s overload.
There would need to be something new and different.”
Lastly, the doctors were asked for ideas on how professionals could provide patients with more
effective educational materials about the risks of ATOD and the resources available to help
decrease substance abuse. The following responses were representative of the whole:
“Make sure doctors address the issue. We can do a better job of asking some of the
questions. Brochures need to be placed in “first visit” bags. We need to spend the time oneon-one and be straightforward.”
“One-on-one is most effective.”
Discussion
Several themes emerged from this study. First, a large proportion of women did not seek treatment
for ATOD abuse because of fear of losing their children or fear of repercussions or other legal
proceedings. Many were afraid that their children would be taken because of their involvement in a
treatment program or that information gathered would be used against them in court or other
proceedings. Further, many were concerned about possible repercussions to self and family. In
some cases, these fears originate from attitudes of others that women with ATOD addictions are bad
mothers. Participants also indicated they were afraid they could not afford treatment or would have
to wait long periods of time before acquiring appropriate treatment. Some even indicated a lack of
confidence in the established social and legal systems. These concerns highlight the plight of a
population of women who are often marginalized. Intervention is needed to increase the percentage
of women in high risk groups who have knowledge of the effects of ATOD.
A second pertinent theme is women’s source of information for their health. Responses from
participants show that only 43% of women obtained their health care information from their
provider. The remaining 57% cited other sources of information including family, treatment centers,
TV and Internet. This finding is consistent with findings in the email survey sent to the
professionals, which indicated that only 37% used tangible educational material to educate patients.
Most medical professionals did indicate that they verbally instructed and educated their patients.
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This indicates that successful patient education may require professionals to provide materials
including brochures, fact sheets or other educational aids in addition to verbal instruction.
Additionally, health care professionals may also need to consider educational materials that provide
information on how to access assistance for mothers who are using or dependant on ATOD. While
72% of women indicated that they ‘would follow’ the advice of their health care provider, fewer
than two percent obtained any information on treatment for addictions from their health care
provider. In contrast, four of the 60 reported getting information from the Internet and six from TV.
While ATOD treatment may not be the focus of women’s health care, professionals’ inclusion of
tangible information on treatment and care may be a prudent step in the educational process for
women who are either pregnant or of childbearing age due to the impact of ATOD on unborn
children.
Health care professionals can have a profound impact on women during their childbearing years.
More than 70% of women indicated they would follow the advice of their health care professional
while the remaining 28% noted that they “might follow” their health care professional’s advice. In
contrast, when women were asked about following the advice of other sources of information (e.g.,
TV, Internet, or radio), positive responses decreased dramatically. Only 15% of respondents would
follow the advice given on the Internet, 9% for radio information and only 5% for information
found on TV. These statistics confirm the trust these women have in their health care provider. This
statistic only emphasizes the need for clear and effective communication between patient and
professional. While nearly all of the health care professionals reported educating their patients, only
37% reported using a tangible form of educational material. While verbal educational techniques
are effective for some, a tangible form of educational material may be more appropriate for others.
This suggestion is validated in a study on proper medication administration written by Brown,
Wright and Christensen (1987). They note that written and verbal instruction is far superior to
verbal instruction alone.
Survey results assessing screening and educational practices by professionals emphasized not only
the importance of identifying the most appropriate method of conveying information but the
appropriate time to convey the information. The number of professionals who screened pregnant
women for ATOD use on initial visit was much higher than those who screened women of childbearing age. Across the four substances (alcohol, tobacco, illicit drugs and prescription drugs) there
was a notable difference in screening practices employed when treating pregnant women versus
women of childbearing age. This finding inevitably raises the question of whether prevention of
ATOD abuse through appropriate screening and education is possible prior to pregnancy. Without
such screening and education, a woman’s first knowledge of the effects of ATOD on an unborn
child may be when she seeks prenatal care after becoming pregnant. Due to the rapid development
of the fetus in the first trimester, this concern should be addressed constantly by health care
professionals as well other social programs that work with women of childbearing age.
While there is a significant need to decrease the number of women who abuse ATOD, especially
when pregnant, there seems no easy solution. Professionals were asked what the primary barriers
were to screening and educating their patients. The number one response was a lack of time. In
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today’s health care community, with pressure for professionals to increase productivity, time
continues to be a significant factor in quality of care. Rising insurance premiums, increasing
lawsuits and decreasing reimbursement have pushed health care professionals to see more patients
in less time. Unfortunately, this practice often leads to less one-on-one time with patients. This time
is needed to be able to discuss in depth the needs of the patient as well as to educate and screen
patients. When care is rationed by time, screening and education may be the elements of the visit
that are cut.
This frustration was reiterated during phone interviews with the physicians. One of the questions
asked was what the doctors felt could be done to improve the effectiveness of education on the risks
of ATOD use. Several responded that they (the doctors) needed to spend more “one-on-one time”
with the patients. A second questioned the reason that so few doctors wanted to be sent additional
information on screening and education (fewer than 60%). Several of those interviewed noted that
many doctors in the geographical area of this study “don’t think it is really an issue in the area”.
While that attitude may not be common outside of that particular area, it was noted by multiple
physicians interviewed in this study. The comment may be a key to why there is a lack of effective
screening of and education for women in this particular geographical area.
Future research aimed at improving ATOD education and screening for women should address
several issues. First, there is a need to assess the most effective form of education for women in the
study population. While it is understood that each situation will be different, knowledge of best
practices for educating women in treatment centers would provide a good starting point. Second, to
improve screening for all women, researchers may investigate the reasons for the differences in
screening women who are pregnant and those who are not. As this study noted, women who were
pregnant were much more likely to be screened on their initial visit for ATOD than were women
who were not pregnant but were of childbearing age. There are several possible reasons for this
difference which may lead to better screening for all women. Finally, research could be conducted
into methods for professionals to overcome barriers, such as a lack of time, to screening and
educating women appropriately.
This study has several limitations. The samples of women and medical professionals were done as
convenience samples. These samples are representative of urban areas in Utah, but may show little
resemblance to samples from rural areas of Utah. Second, generalization to other areas in the United
States would be difficult due to the unique ethnic and religious demographics of Utah. Further, data
were not collected on survey administration techniques. Despite the pre-administration training and
small number of survey administrators, lack of inter-rater error data does not allow any statement to
be made in defense of consistent administration.
Conclusion
The purposes of this study have been to look at knowledge, attitudes and opinions of women as well
as screening and educational practices of professionals when dealing with ATOD use. While there
is still a gap in what is ideal and what is reality, this study has presented useful data to be considered
when working to improve not only knowledge of women involved in ATOD use and the screening
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and educational practices of health care professionals providing services for women’s obstetric and
gynecological needs.
The results of this study indicate that there is a gap between what is being done to avoid ATODadverse birth traumas and what needs to be done. Women who were involved with treatment centers
for ATOD addiction responded that one of the greatest barriers to obtaining information is fear.
Proper education, regarding not only the effects of ATOD use on the unborn child but on the
ramifications of revealing the ATOD use to professionals, is paramount in the fight to decrease the
risk of ATOD-related birth trauma. This education may be disseminated from a number of sources
including health care professionals, social service workers, school programs or religious
institutions. The source may not be as important as simply ensuring that the information is
presented.
Additionally, despite the efforts of professionals, screening and educational practices have been
noted to be only somewhat effective. Education of professionals as to the most effective ways of
informing patients involved in ATOD use is another area of concern. Current practices are only
moderately effective in conveying information clearly. While women who engage in ATOD use
report that they are likely to follow their health care provider’s advice, relatively few report that
they have received effective information regarding ATOD use. Noting the lack of time with patients
as a concern expressed by many health care professionals, the effective disseminating of
educational information is critical for both groups (patients and professionals).
While current practices are not as effective as would be ideal, this study indicates that both patients
and practitioners are willing to work for improvement. Women enrolled in treatment centers have
indicated a desire to follow instructions from health care providers. Practitioners have indicated a
desire to become better at educating and screening women of child-bearing age and those who are
pregnant. With important information gathered from both groups in this study it is now possible to
find and implement methods of education and screening to bridge the existing gap.
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Appendix 1.
Questions to Women in Treatment Centers
Please answer the following questions to help us know what works best for you.
Where do you get health information and advice that you follow?
________________________________________________________________________
Where would you get health information and advice if you were pregnant?
________________________________________________________________________________
If you wanted help to quit drinking or using substances, where would you go for information about
treatment services?
________________________________________________________________________________
If you are currently in treatment, how did you find the place where you are getting help?
________________________________________________________________________________

If a doctor talks to you about health information would you follow the advice? (Check one)
I would follow
I might follow
I would not follow

When a health care professional talks to you, what is the best way to give you information?
(Check all that apply to you)
A face-to-face discussion, with questions and answers

Over the telephone

Face-to-face discussion with written information to read at a later date
Other: List _________________________________________________________________________

If your doctor gives you a brochure with health information would you: (Check one answer)
Read the brochure
Follow the advice
Throw the brochure away without reading

When you hear health information on the radio, do you believe it to be true? (Check one answer)
Information is true
Information is probably true
Information is not true
Would you follow the advice you heard on the radio? (Check one answer)
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I would follow

I might follow

I would not follow

When you see health information on television, do you believe it to be true? (Check one answer)
Information is true
Information is probably true
Information is not true

Would you follow the advice you see on television? (Check one answer)
I would follow
I might follow
I would not follow

When you read health information ‘on line’, do you believe it to be true? (Check one answer)
Information is true
Information is probably true
Information is not true

Would you follow the advice you read ‘on line’? (Check one answer)
I would follow
I might follow
I would not follow

What online website do you trust for health information? (Please list)
____________________________

If warning signs about the harmful effects of drinking during pregnancy were placed where liquor is
sold and served would the warnings make you think about not drinking during pregnancy? (Check
one answer)
I would stop drinking

I would probably stop drinking

I would not stop drinking

Would you ask your doctor’s advice about drinking alcohol during pregnancy because you saw
information where liquor is sold and served? (Check one answer)
Yes
Probably
Would Not

What were your fears about getting into treatment? (Check all that apply to you)
That treatment would not work for me
That my child(ren) would be taken away from me
That I would be put in jail because I was pregnant
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That I could not afford to pay for the
treatment
That I did not have time to go to
treatment
That I would have to wait to get
treatment

That the information I give during treatment about my alcohol/drug use would be used against
me in court
Other: Please list
____________________________________________________________________

What is your ethnicity? (Check one answer)
African American
Asian
Hispanic
White

What is your age? (Check one answer)
12 years and younger
13-19 years

Native American

20-29 years

Pacific Islander

30 years and older

Please check the phrases that make the most sense to you and that send the strongest message
not to use alcohol, tobacco or other drugs during pregnancy. (You may check more than
one)
Drinking any kind of alcohol when you are pregnant can hurt your baby.
Alcohol can hurt an unborn baby.
During pregnancy there is no safe amount of alcohol.
Did you know that if you drink alcohol when you are pregnant, you can hurt your unborn
baby?
Smoking can harm an unborn baby.
Smoking can harm babies before they are born.
Stop and think. If you’re pregnant don’t drink.
Using any drug when you are pregnant is risky.
Drugs can harm a baby before and after it is born.
Don’t take any drug without your health care provider’s advice.
Please check the phrases that you feel would have encouraged you to seek help. (You may
check more than one)
A pregnant woman who stops drinking as soon as possible can improve her chances of
having a healthy baby.
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The best way to make sure your baby isn’t harmed by smoking is to quit.
There are many ways to stop smoking. Check with your doctor for ideas to help you quit.
Fetal Alcohol Spectrum Disorders are 100% preventable if a woman does not drink alcohol
during pregnancy.
The best choice is not to drink at all when you are pregnant.
Stopping drinking can be very hard. But there are many people who will help you.
Even if you have tried to stop drinking before, try again. Don’t give up.
When a pregnant woman uses alcohol, her baby does too. That’s why not drinking alcohol
throughout pregnancy and breastfeeding is the best gift a mother can give her child—it is a
gift that lasts a lifetime.
Drugs and alcohol don’t have to be part of your or your baby’s life.
It is never too late to stop using a drug. A mother who stops using drugs at any time during
pregnancy increases the chance that her baby will be born healthy.
Alcohol can harm your baby: Be an alcohol free mother-to-be.
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Appendix 2
Health Care Provider Survey

Background
In 2008, the Utah Legislation passed H.B. 38 directing the Utah Department of Health to implement a social-marketing
program to educate women of childbearing age about fetal effects from alcohol, tobacco and other drugs (ATOD).
As part of this project, women in substance abuse treatment centers were interviewed and 100% of the women surveyed
said that if a doctor talked to them about health information, they would probably follow the advice given.
The majority (87%) of the respondents said the best way to receive information about ATOD is in a face-to-face
discussion with their doctor and to have adequate time for questions and answers. They also requested written
information to take home to read at a later time.
Your responses will help us meet the needs of women at risk of ATOD abuse.
Please click the "submit" button below to continue.

Did you know?
* More than one-third (34%) of pregnancies in Utah are unplanned1.
* There were over 6,500 Utah women entering substance abuse treatment centers in 2007 and of these, 6.2% were
pregnant2.
* Binge drinking among Utah women ages 18-34 years is reported to be 6.8%. For women younger than 18, the rate is
7.3%. Hispanic women have an even higher binging rate at 9.2%1.
* Close to half (44%) of Utah women mentioned that their doctors did not ask how much alcohol they drink3.
* Half (50%) of Utah women reported that their doctor did not talk to them about how alcohol, tobacco and other drugs
affect a fetus3.
* A study published in the American Journal of Preventive Medicine reported that a focused alcohol discussion reduced
problem drinking by an average of 17%. This article also suggested that alcohol screening was as cost effective as Pap
smears or bowel-cancer screenings4.

1. Utah Behavioral Risk Factor Surveillance System (BRFSS) 2005-2007.
2. 2007 Division of Substance Abuse and Mental Health (DSAMH) Annual Report.
3. Pregnancy Risk Assessment Monitoring System (PRAMS) 2005 Report.
4. Solberg LI, Maciosek MV, Edwards NM. Primary Care Intervention to Reduce Alcohol Misuse: Ranking Its Health
Impact and Cost Effectiveness. Am J Prev Med 34(2), 2008.
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Questions about women of childbearing age
[Questions with an asterisk (*) require input]

Question 1

[Mandatory]

How often do you screen women of childbearing age for possible drug and alcohol abuse?
At initial visit

At each visit

Annually

When suspect
a problem

Never

Alcohol
Tobacco
Methamphetamines
Cocaine
Heroin
Dependence on prescription pain
medication
Question 2

[Mandatory]

What is the most significant barrier to screening women of childbearing age for possible drug and alcohol abuse?
Not enough
time

Not enough
knowledge
about the
effects of
abuse

Not enough
information
about
treatment
for abuse

No contacts
to refer to
treatment

No barriers

N/A

Alcohol
Tobacco
Methamphetamines
Cocaine
Heroin
Prescription pain medication

Questions about pregnant women
[Questions with an asterisk (*) requires input]

Question 3

[Mandatory]

How often do you screen pregnant women for possible drug and alcohol abuse?
At initial visit

At each visit

Alcohol
Tobacco
Methamphetamines
Cocaine
Heroin
Dependence on prescription pain
medication
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Annually

When suspect
a problem

Never

Question 4

[Mandatory]

What is the most significant barrier to screening pregnant women for possible drug and alcohol abuse?
Not enough
time

Not enough
knowledge
about the
effects of
abuse

Not enough
information
about
treatment
for this type
of abuse

Not
contacts to
refer for
treatment

No barriers

N/A

Alcohol
Tobacco
Methamphetamines
Cocaine
Heroin
Prescription pain medication
Question 5
Who does the screening at your clinic?

Question 6
How much time do you or your staff spend with patients on these issues?
None
Less than 5 minutes
Less than 10 minutes
10 to 15 minutes
More than 15 minutes
Other, please specify

Question 7

[Mandatory]

Do you use any educational materials when talking to women of childbearing age and / or pregnant women about alcohol,
tobacco, and drugs (ATOD)?
Yes
No
Additional Comment

Question 8
If yes, what type of educational materials do you use when talking to women of childbearing age and / or pregnant women
about alcohol, tobacco, and drugs? (Please check all that apply)
Brochure
Fact sheet
Website
Other, please specify
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Question 9
Based on above question, please indicate from which agency you get the following information:
Brochure
Fact sheet
Website
Other
Question 10
What other educational materials or assessment tools would help you talk with your patients about alcohol, tobacco, and
drugs (ATOD)?

Question 11
Would you be interested in receiving substance abuse educational materials or assessment tools to assist you with
screening patients or patient education?
(If you answer "no", please skip to question # 14)
Yes
No
Question 12
In what format would you like these materials?
(Please check all that apply)
Brochure
Fact sheet
Website
CD/DVD
Other, please specify

Question 13
What is your preferred method to receive such materials? (Please check all that apply)
Mail
Email
Website
Conference
Podcast
CD / DVD
Other, please specify
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Question 14
Are you aware of the legal protections provided by law or court rule for your patients that prohibit the release of
information relating to treatment without patient consent?
Yes
No
Question 15
Would you be interested in receiving more information about the law?
Yes
No
Question 16
If yes, what is your preferred method for receiving more information about the law? (Please check all that apply)
Mail
Email
Website
Conference
Podcast
CD / DVD
Other, please specify

This section is to obtain basic demographic information about you.
[Questions with an asterisk (*) require input]

Question 17

[Mandatory]

Please describe your primary profession:
Physician
Osteopathic physician
Nurse
APRN
CNM
Physician assistant
Other, please specify

Question 18
Please indicate your practice location:
(Please select from the drop down list)
Urban
Rural
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Question 19
Please indicate your gender:
Male
Female
Question 20
If you indicated that you would be interested in receiving ATOD educational materials and assessment tools, please
provide your contact information below:
Name
Company
Address
City
State
Zip
Question 21
Please provide your email address (optional):

Question 22
Please list any comments or suggestions you may have to improve the services for women of childbearing age in Utah.

Thank you for your participation!

Questions/comments should be directed to:
Julia Robertson
Utah Department of Health
1-800-822-2229
jrobertson@utah.gov

Thank you for your valuable time and feedback!
Please click this link to visit the Pregnancy Risk Line website. <http://health.utah.gov/prl>
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Appendix 3.
Questions from the phone interview with physicians
Part I—Screening Practices
1. Do you screen all pregnant women at your clinic for alcohol, tobacco, and other drug use?
2. Do you typically screen women of childbearing age at your clinic for alcohol, tobacco, and other
drug use?
3. Is the screening you do different for women who are pregnant vs. those who are of childbearing
age but not pregnant.
4. If you answered yes to question #1 and/or #2, do the sample screening tools we sent look like the
screenings that you typically use in your office?
Part II—Materials
1. Do you provide information to educate your patients as to the effects of alcohol, drugs, and
tobacco on unborn children?
2a. What format do you usually use to provide this information?
2b. Do you think that the way you share information is effective for patients after the initial visit
where the material is introduced (i.e. Do you think they ever look at it again?)
3. Do you attempt to educate ALL women of childbearing age or only those who are pregnant?
Part III. Additional Information
1. As a medical practitioner, why do you think that there were only 40% who requested
additional info? (Lack of interest, already have info and don’t want to see additional info,
overload, lack of time, etc.)
2. What might be done to better meet the needs of both patients and medical professionals
regarding the need to screen pregnant women and women of child-bearing age for alcohol,
tobacco, and other drugs?
3. Do you have any ideas about how medical professionals can more effectively provide
patients with educational materials about both the risks of alcohol, tobacco, and other drug
use and the resources available to help individuals quite using these substances?
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